Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Anal Cancer Stage III A”

31 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 31 results

Large-scale testing (Phase 3)UnknownNCT05374252
What this trial is testing

Chemoradiotherapy Combined With or Without PD-1 Blockade in Anal Canal Squamous Carcinoma Patients

Who this might be right for
Anal Canal Cancer Stage IIIAnal Squamous Cell CarcinomaAnal Canal Cancer+1 more
Sixth Affiliated Hospital, Sun Yat-sen University 102
Early research (Phase 1)Study completedNCT00005842
What this trial is testing

Trastuzumab Plus R115777 in Treating Patients With Advanced or Metastatic Cancer

Who this might be right for
Cancer
National Cancer Institute (NCI) 24
Large-scale testing (Phase 3)Study completedNCT01651949
What this trial is testing

Multivalent HPV (Human Papillomavirus) Vaccine Study in 16- to 26-Year Old Men and Women (V503-003)

Who this might be right for
Genital WartsAnal CancerAnal Intraepithelial Neoplasia
Merck Sharp & Dohme LLC 2,520
Large-scale testing (Phase 3)Active Not RecruitingNCT04444921
What this trial is testing

EA2176: Phase 3 Clinical Trial of Carboplatin and Paclitaxel +/- Nivolumab in Metastatic Anal Cancer Patients

Who this might be right for
Anal Basaloid CarcinomaAnal Canal Cloacogenic CarcinomaMetastatic Anal Squamous Cell Carcinoma+4 more
National Cancer Institute (NCI) 205
Not applicableWithdrawnNCT04985357
What this trial is testing

Defining the Clinical Potential of Mass Response As a Biomarker for Patient Tumor Sensitivity to Drugs

Who this might be right for
Stage III Breast CancerStage IV Breast CancerStage III Lung Cancer+35 more
Travera Inc
Large-scale testing (Phase 3)UnknownNCT05668572
What this trial is testing

A Phase III Trial Evaluates the Efficacy, Immunogenicity and Safety Profile of HPV Vaccine

Who this might be right for
Human Papillomavirus Infection
Beijing Health Guard Biotechnology, Inc 12,000
Large-scale testing (Phase 3)Study completedNCT00025090
What this trial is testing

Radiation Therapy Plus Fluorouracil With or Without Additional Chemotherapy in Treating Patients With Primary Anal Cancer

Who this might be right for
Anal Cancer
University College London (UCL) Cancer Institute 600
Early research (Phase 1)Study completedNCT00020579
What this trial is testing

MS-275 in Treating Patients With Advanced Solid Tumors or Lymphoma

Who this might be right for
Cancer
National Institutes of Health Clinical Center (CC) 75
Testing effectiveness (Phase 2)Active Not RecruitingNCT04230759
What this trial is testing

Radiochemotherapy +/- Durvalumab for Locally-advanced Anal Carcinoma. a Multicenter, Randomized, Phase II Trial of the German Anal Cancer Study Group

Who this might be right for
Anal CancerAnal CarcinomaAnal Cancer Stage III+1 more
Goethe University 180
Large-scale testing (Phase 3)Active Not RecruitingNCT06866574
What this trial is testing

A Phase III Trial to Evaluate the Efficacy, Immunogenicity and Safety of a Recombinant Human Papillomavirus 9-Valent (Types 6, 11, 16, 18, 31, 33, 45, 52, 58) Vaccine (E.Coli) in Chinese Males

Who this might be right for
Penile/Perineal /Perianal Intraepithelial NeoplasiaAnal Intraepithelial NeoplasiaPenile/Perianal/Perineal Cancer+2 more
Xiamen University 9,300
Early research (Phase 1)Study completedNCT00049296
What this trial is testing

Thalidomide and Docetaxel in Treating Patients With Advanced Cancer

Who this might be right for
Cancer
Case Comprehensive Cancer Center 26
Testing effectiveness (Phase 2)Study completedNCT00423293
What this trial is testing

Intensity-Modulated Radiation Therapy, Fluorouracil, and Mitomycin C in Treating Patients With Invasive Anal Cancer

Who this might be right for
Anal Cancer
Radiation Therapy Oncology Group 63
Large-scale testing (Phase 3)Study completedNCT02059499
What this trial is testing

Imiquimod, Fluorouracil, or Observation in Treating HIV-Positive Patients With High-Grade Anal Squamous Skin Lesions

Who this might be right for
Anal Intraepithelial NeoplasiaHigh-grade Squamous Intraepithelial LesionHIV Infection
AIDS Malignancy Consortium 91
Early research (Phase 1)Study completedNCT00004074
What this trial is testing

Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu

Who this might be right for
Advanced Adult Primary Liver CancerAnaplastic Thyroid CancerBone Metastases+124 more
National Cancer Institute (NCI) 15
Early research (Phase 1)Ended earlyNCT01324141
What this trial is testing

Topical MTS-01 for Dermatitis During Radiation and Chemotherapy for Anal Cancer

Who this might be right for
Anal Cancer
National Cancer Institute (NCI) 6
Early research (Phase 1)Study completedNCT00003704
What this trial is testing

Chemotherapy Plus Radiation Therapy in Treating Patients With Unresectable, Residual, or Recurrent Colorectal Cancer

Who this might be right for
Cancer
Alliance for Clinical Trials in Oncology 51
Large-scale testing (Phase 3)Active Not RecruitingNCT03233711
What this trial is testing

Nivolumab After Combined Modality Therapy in Treating Patients With High Risk Stage II-IIIB Anal Cancer

Who this might be right for
Anal Basaloid CarcinomaAnal Canal Cloacogenic CarcinomaAnal Margin Squamous Cell Carcinoma+2 more
National Cancer Institute (NCI) 344
Early research (Phase 1)Active Not RecruitingNCT04046133
What this trial is testing

Phase 1b/II Trial of Pembrolizumab Plus IMRT in Stage III/IV Carcinoma of Anus

Who this might be right for
Anal Cancer Stage III AAnal Cancer Stage III B
Cardiff University 52
Testing effectiveness (Phase 2)Active Not RecruitingNCT03074513
What this trial is testing

Atezolizumab and Bevacizumab in Treating Patients With Rare Solid Tumors

Who this might be right for
Appendix AdenocarcinomaHuman Papillomavirus-Related Anal Squamous Cell CarcinomaHuman Papillomavirus-Related Cervical Squamous Cell Carcinoma+18 more
M.D. Anderson Cancer Center 133
Large-scale testing (Phase 3)Study completedNCT00075868
What this trial is testing

Octreotide in Preventing or Reducing Diarrhea in Patients Receiving Chemoradiotherapy for Anal or Rectal Cancer

Who this might be right for
Anal CancerColorectal CancerDrug/Agent Toxicity by Tissue/Organ+1 more
Radiation Therapy Oncology Group 233
Load More Results